Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reyal

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|September 18, 2015
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinomaL Rossi, E Laas, P Mallon, et al.
British Journal of Cancer|January 16, 2015
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based modelsE Laas, P Mallon, M Delomenie, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|July 31, 2023
Impact of ERAS in breast reconstruction with a latissimus dorsi flap, compared to conventional managementG Taba, V Ceccato, O Fernandes, et al.
British Journal of Cancer|June 17, 2015
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapyS Baulies, L Belin, P Mallon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 9, 2011
[Management of inflammatory breast cancer after neo-adjuvant chemotherapy]S Abrous-Anane, A Savignoni, C Daveau, et al.
Breast Cancer Research and Treatment|November 4, 2016
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysisClémentine Jankowski, S Guiu, M Cortet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 16, 2013
Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patientsP Mariani, V Servois, Y De Rycke, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 19, 2010
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]C Daveau, A Savignoni, S Abrous-Anane, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 8, 2012
Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinomaC Ngô, D Mouttet, Y De Rycke, et al.
Plos One|February 2, 2016
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based AssayD Mouttet, M Laé, M Caly, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|September 18, 2015
Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinomaL Rossi, E Laas, P Mallon, et al.
British Journal of Cancer|January 16, 2015
Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based modelsE Laas, P Mallon, M Delomenie, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|July 31, 2023
Impact of ERAS in breast reconstruction with a latissimus dorsi flap, compared to conventional managementG Taba, V Ceccato, O Fernandes, et al.
British Journal of Cancer|June 17, 2015
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapyS Baulies, L Belin, P Mallon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 9, 2011
[Management of inflammatory breast cancer after neo-adjuvant chemotherapy]S Abrous-Anane, A Savignoni, C Daveau, et al.
Breast Cancer Research and Treatment|November 4, 2016
Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysisClémentine Jankowski, S Guiu, M Cortet, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 16, 2013
Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patientsP Mariani, V Servois, Y De Rycke, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 19, 2010
[Early stage breast cancer: is exclusive radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?]C Daveau, A Savignoni, S Abrous-Anane, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 8, 2012
Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinomaC Ngô, D Mouttet, Y De Rycke, et al.
Plos One|February 2, 2016
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based AssayD Mouttet, M Laé, M Caly, et al.
Pageof 5